C12Y 301/22
Endodeoxyribonucleases producing 3'-phosphomonoesters
Official title: Endodeoxyribonucleases producing 3'-phosphomonoesters (3.1.22)
C12Y301/22 (Endodeoxyribonucleases producing 3'-phosphomonoesters) appears on 30 US grants and 56 published applications in this corpus.
Search patents in C12Y- Granted patents
- 30
- Published applications
- 56
- Assignees
- 31
- Inventors
- 110
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 1 | 1 |
| 2005 | 1 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 3 | 10 |
| 2016 | 1 | 2 |
| 2017 | 1 | 3 |
| 2018 | 3 | 2 |
| 2019 | 1 | 3 |
| 2020 | 2 | 3 |
| 2021 | 3 | 4 |
| 2022 | 3 | 5 |
| 2023 | 1 | 3 |
| 2024 | 2 | 6 |
| 2025 | 4 | 6 |
| 2026 | 2 | 4 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Dnase variants21 Jul 2026US 12,686,857 B2Novozymes A/S
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations20 Jan 2026US 12,529,100 B2Roche Sequencing Solutions, Inc.
- Methods for detecting binding of peptide-MHC monomers to T cells21 Oct 2025US 12,449,419 B110x Genomics, Inc.
- Modular genetically engineered cell and methods of generation thereof23 Sep 2025US 12,421,529 B2Science Incorporated
- Gene-modifying endonucleases8 Jul 2025US 12,351,818 B2Amber Bio Inc.
- Epigenetic editing tool for targeting hepatitis b virus gene9 Apr 2026US 2026/0097133 A1Epigenic Therapeutics Pte. Ltd.
- Lentivirus with altered integrase activity26 Feb 2026US 2026/0055430 A1Flagship Pioneering Innovations VI, LLC
- Novel compositions for disrupting biofilms12 Feb 2026US 2026/0041743 A1The Trustees of Indiana University
- Modular genetically engineered cell and methods of generation thereof1 Jan 2026US 2026/0002178 A1Science Incorporated
- Gene-modifying endonucleases13 Nov 2025US 2025/0346926 A1Amber Bio Inc.
Most cited
By later US patents
- Methods for correcting presenilin point mutations123US 9,068,179 B1President and Fellows of Harvard College · 2015
- Methods for nucleic acid editing121US 9,840,699 B2President and Fellows of Harvard College · 2017
- Fusions of Cas9 domains and nucleic acid-editing domains74US 11,053,481 B2President and Fellows of Harvard College · 2021
- Cas variants for gene editing73US 11,124,782 B2President and Fellows of Harvard College · 2021
- Cas variants for gene editing72US 10,465,176 B2President and Fellows of Harvard College · 2019